TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking
Hagens Berman is investigating the alleged claims and urges investors who purchased TransMedics shares and suffered substantial losses to submit your losses now.
Lead Plaintiff Deadline: Apr. 15, 2025
Visit:
844-916-0895
The TransMedics Group (TMDX) Class Action
The complaint alleges that TransMedics made false and misleading statements, while failing to disclose crucial information. Specifically, the suit contends that TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to boost business and revenue. Furthermore, it alleges that the company engaged in unsafe practices, concealed safety problems, and generally lacked adequate safety oversight, exposing TransMedics to heightened regulatory risk.
The lawsuit details two events that allegedly disclosed defendants' misconduct to the market that adversely impacted the company's stock price. On February 21, 2024, Representative Paul Gosar issued a letter accusing TransMedics of misappropriating corporate resources. The allegations were subsequently reported by The Daily Caller on February 22, 2024, causing a drop in TransMedics' stock price, according to the complaint.
More recently, on January 10, 2025, activist short seller Scorpion Capital released a report leveling accusations against TransMedics, including overbilling hospitals, coercing customers into using specific services, and providing patients with organs rejected by reputable physicians via doctors allegedly paid by TransMedics.
This report further depressed the company's stock price, the lawsuit claims.
Prominent investor rights firm Hagens Berman Sobol Shapiro LLP is probing whether TransMedics misled investors regarding its sales practices.
'We are looking into claims that TransMedics engaged in improper billing practices and concealed safety issues. These allegations, if true, could have significant implications for both patients and investors,' said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in TransMedics and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to frequently asked questions about the TransMedics case and our investigation, read more »
Whistleblowers: Persons with non-public information regarding TransMedics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
Contact:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
33 minutes ago
- Business Insider
Stifel Nicolaus Reaffirms Their Buy Rating on Proficient Auto Logistics, Inc. (PAL)
In a report released on August 15, J. Bruce Chan from Stifel Nicolaus maintained a Buy rating on Proficient Auto Logistics, Inc., with a price target of $13.00. The company's shares closed yesterday at $7.77. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bruce Chan covers the Industrials sector, focusing on stocks such as Forward Air, XPO, and Hub Group. According to TipRanks, Bruce Chan has an average return of 0.7% and a 50.20% success rate on recommended stocks. In addition to Stifel Nicolaus, Proficient Auto Logistics, Inc. also received a Buy from William Blair's Ryan Merkel in a report issued on August 12. However, on August 14, TR | OpenAI – 4o reiterated a Hold rating on Proficient Auto Logistics, Inc. (NASDAQ: PAL). The company has a one-year high of $20.58 and a one-year low of $5.88. Currently, Proficient Auto Logistics, Inc. has an average volume of 179.3K. Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PAL in relation to earlier this year. Earlier this month, Amy F. Rice, the President & COO of PAL sold 6,100.00 shares for a total of $47,702.00.
Business Insider
an hour ago
- Business Insider
‘History Doesn't Favor the Bulls,' Says Top Investor About Palantir Stock
Palantir (NASDAQ:PLTR) stock has been on a tear – no secret there – with shares up nearly 450% over the past year. But the surge reflects more than just AI hype: revenues are rising quickly, new clients keep joining, and management has consistently raised its outlook. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In fact, the company recently crossed the $1 billion quarterly revenue milestone for the first time. While Palantir built its reputation on U.S. government security contracts, its latest results show momentum is spreading beyond that niche. U.S. commercial revenue jumped 93% year-over-year – clear evidence that businesses across the economy are finding enormous value in Palantir's expanding suite of AI tools. And Palantir doesn't seem to be taking its foot off the gas pedal. The company raised its Q3 revenue guidance to $1.087 billion, which would represent 50% year-over-year revenue growth. The biggest – and perhaps, only – knock against the company is its sky-high valuation. Seizing on this concern, top investor Julian Lin offers a word of caution. 'Despite stellar performance, I believe PLTR stock's valuation is in bubble territory, far exceeding historical tech bubbles,' explains the 5-star investor, who is among the top 1% of TipRanks' stock pros. There's one particular historical example that Lin mentions, which could cause PLTR bulls to start sweating. That would be Cisco, which was trading at 30x sales before it came crashing down during the 2000 stock bubble. PLTR was recently trading as high as 100x sales, reminds the investor. 'History has proven time and time again that valuations always end up mattering,' emphasizes Lin. As great as the company has been performing, Lin points out that PLTR's share price is already pricing in years of future growth. While this has arguably been the case for much of the past year, eventually the investor believes the bubble will pop. This will especially be the case when some negative catalysts enter the picture, which could come in the form of higher inflation or AI-related job losses. This could cause a massive re-rating for PLTR, which Lin suggests could reach a downside of some 80%. For that reason, the investor is getting out of dodge and is urging bulls to reconsider their commitment to PLTR. 'I just know that history does not shine well when valuations reach irrational exuberance. I reiterate my Strong Sell rating for the stock,' concludes Lin. (To watch Julian Lin's track record, click here) How does Wall Street see Palantir? The consensus view is less dramatic but hardly bullish. With 13 Hold ratings, 5 Buys, and 2 Sells, PLTR currently carries a consensus Hold (i.e., Neutral) rating. The Street's average 12-month price target of $154.56 implies ~11% downside from current levels. (See PLTR stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
an hour ago
- Yahoo
Blockchain Lender Figure Joins Crypto IPO Rush With Nasdaq Listing Bid Under 'FIGR'
Figure, the blockchain-powered lender founded by SoFi co-founder Mike Cagney, has filed with the Securities and Exchange Commission for an initial public offering as the latest entrant in a growing crypto IPO wave. The company plans to list its Class A shares on the Nasdaq under the ticker FIGR, with Goldman Sachs, Jefferies, and BofA Securities serving as lead underwriters. Figure's path to public markets has been years in the making. In 2021, it launched a special purpose acquisition company, Figure Acquisition Corp. I, with a $250 million raise aimed at acquiring growth-stage businesses using Provenance as an efficiency layer, however in the end this SPAC did not bring Figure to market. A friendlier regulatory stance under the Trump administration and buoyant crypto and stock markets have set the stage for a surge of digital asset firms tapping the equity markets, including crypto exchange Bullish which is the owner of CoinDesk. The company last month merged with Figure Markets, a blockchain marketplace also launched by Cagney that issues YDLS, a yield-bearing stablecoin structured as a tokenized money market fund. Financials disclosed in the S-1 show revenue up 22.4% in the first half of 2025 to $190.6 million, with net income of $29 million compared with a $13 million loss a year earlier. According to the filing with the SEC, proceeds from the IPO will fund working capital and potential acquisitions, with no dividends in to access your portfolio
